Skip to main content
. 2017 Jul 26;174(17):2912–2928. doi: 10.1111/bph.13921

Figure 3.

Figure 3

Effects of DKS26 on blood glucose, oral glucose tolerance, feeding and body weight in db/db diabetic mice after 30 days of administration. (A) Plasma GSP levels. (B) and (C) oral glucose tolerance test and the AUC. (D) Water intake expressed as the average of the last week of daily water consumption in mice of each group. (E) Food intake expressed as the average of the last week of daily food consumption in mice of each group. (F) Body weight. OA represents oleanolic acid; MET represents metformin. Values are expressed as mean ± SEM with db/db control and metformin n = 7 and OA control and DKS26 group n = 8. Compared with db/db control group, * P < 0.05; compared with OA group, P < 0.05.